ENvue Medical, Inc. FEED
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.06M | -20.14M | -18.19M | -6.76M | -8.27M |
| Total Depreciation and Amortization | 951.00K | 1.10M | 897.00K | 639.00K | 382.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.85M | 6.35M | 6.26M | -2.80M | 95.00K |
| Change in Net Operating Assets | 618.00K | 351.00K | 1.66M | 1.68M | 1.69M |
| Cash from Operations | -11.65M | -12.34M | -9.37M | -7.24M | -6.11M |
| Capital Expenditure | -95.00K | -72.00K | -60.00K | -37.00K | -9.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | 148.00K | 148.00K | 148.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -95.00K | -72.00K | 88.00K | 111.00K | 139.00K |
| Total Debt Issued | 0.00 | 610.00K | 1.66M | 3.66M | 1.66M |
| Total Debt Repaid | -1.00M | -3.08M | -3.08M | -3.08M | -2.08M |
| Issuance of Common Stock | 26.06M | 31.31M | 27.41M | 25.45M | 8.32M |
| Repurchase of Common Stock | -- | -- | -- | -- | -27.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -16.26M | -14.78M | -13.22M | -13.22M | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 12.00K | 12.00K | 12.00K | -- | -- |
| Cash from Financing | 8.82M | 14.08M | 12.79M | 12.82M | 7.87M |
| Foreign Exchange rate Adjustments | 5.00K | 1.00K | 0.00 | -12.00K | -12.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.92M | 1.66M | 3.50M | 5.68M | 1.89M |